A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1

Histone deacetylase (HDAC) inhibitors are considered novel agents for cancer chemotherapy. We previously investigated MHY219, a new HDAC inhibitor, and its potent anticancer activity in human prostate cancer cells. In the present study, we evaluated MHY219 molecular mechanisms involved in the regula...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Biomol Ther (Seoul)
Main Authors: De, Umasankar, Kundu, Soma, Patra, Nabanita, Ahn, Mee Young, Ahn, Ji Hae, Son, Ji Yeon, Yoon, Jung Hyun, Moon, Hyung Ryoung, Lee, Byung Mu, Kim, Hyung Sik
פורמט: Artigo
שפה:Inglês
יצא לאור: The Korean Society of Applied Pharmacology 2015
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4556203/
https://ncbi.nlm.nih.gov/pubmed/26336583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4062/biomolther.2015.026
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים